[The use of proteolytic enzymes in the treatment of metastasizing malignant melanona].
D004342:Drug Hypersensitivity; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects; D008545:Melanoma / Q000188:drug therapy*; D009362:Neoplasm Metastasis / Q000188:drug therapy; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D010447:Peptide Hydrolases
Anwendung proteolytischer Enzyme bei der Behandlung metastasierter Melanomalignome?